Jaguar Health, Inc.
JAGX
$12.98
$1.119.35%
NASDAQ
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | 12.90% | 14.22% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 12.90% | 14.22% | |||
| Cost of Revenue | 2.96% | 26.70% | |||
| Gross Profit | 15.00% | 11.90% | |||
| SG&A Expenses | 13.64% | -0.89% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 12.50% | 4.56% | |||
| Operating Income | -12.32% | -0.90% | |||
| Income Before Tax | -2.13% | -4.08% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | -2.13% | -4.08% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | 88.02% | 22.79% | |||
| Net Income | -0.67% | -3.81% | |||
| EBIT | -12.32% | -0.90% | |||
| EBITDA | -13.13% | -0.56% | |||
| EPS Basic | 20.78% | 73.97% | |||
| Normalized Basic EPS | 21.48% | 74.01% | |||
| EPS Diluted | 20.78% | 73.97% | |||
| Normalized Diluted EPS | 21.48% | 74.01% | |||
| Average Basic Shares Outstanding | 27.08% | 298.72% | |||
| Average Diluted Shares Outstanding | 27.08% | 298.72% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||